Skip to main content
. 2016 Oct 28;11:2691–2700. doi: 10.2147/COPD.S114548

Table 3.

Baseline characteristics of the study patients

Variables CG TG
Anthropometric data
Gender (M/F) 7/7 8/6
Age (years) 64±5.6 61±5.4
Height (m) 1.65±0.07 1.65±0.08
BMI (kg/m2) 25.9±2.9 25.7±3.8
Pulmonary function
FEV1 (% pred) 42.6±9.5 45.9±15.5
FEV1/FVC ratio 0.49±0.09 0.56±0.13
Functional exercise capacity
6MWT (m) 439±103 473±68
BODE (I/II/III/IV; n) 3/5/3/1 6/6/2/0
Compartmental volumes (mL)
At rest
 URC 94±54 100±44
 LRC 49±37 63±42
 ABD 295±114 268±117
During exercise with workload
 URC 202±93 161±83
 LRC 97±93 114±112
 ABD 604±253 556±222
Inspiratory muscle activity (RMS, 10−3 mV)
At rest
 Sternocleidomastoid 0.010±0.01 0.011±0.01
 Upper intercostal 0.008±0.01 0.009±0.005
 Diaphragm 0.006±0.002 0.007±0.003
 Rectus abdominis 0.007±0.001 0.007±0.002
During exercise with workload
 Sternocleidomastoid 0.010±0.01 0.020±0.02
 Upper intercostal 0.009±0.002 0.020±0.04
 Diaphragm 0.013±0.01 0.010±0.01
 Rectus abdominis 0.009±0.005 0.010±0.01

Note: Data are presented as mean ± standard deviation, except BODE which is expressed by the number of patients.

Abbreviations: ABD, abdominal; BMI, body mass index; BODE, Body-mass index, airflow Obstruction, Dyspnea, and Exercise; CG, control group; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; LRC, lower ribcage; M/F, male/female; 6MWT, 6-minute walk test; pred, predicted; RMS, root mean square; TG, treatment group; URC, upper ribcage.